Skip to main content

Laser meets life sciences

Startup Modulux3D Opens New Doors in Preclinical R

Using patented laser technology, the innovative startup Modulux3D creates realistic models of human tissues and organs with a 3D bioprinter. The founders offer a promising alternative to animal testing in pharmaceutical research. Born out of research at Goethe University, the startup benefits from the Futury Startup Factory, a collaborative initiative involving the Rhine-Main Universities. The goal is to translate basic research into practical applications.

Animal testing remains a cornerstone of preclinical research to this day. At the same time, it is considered ethically sensitive, costly, and only partially transferable to humans. This is precisely where Modulux3D steps in: the interdisciplinary team has developed a system called the LUMINATE 3D bioprinter, which produces human tissue models with exceptional spatial precision. The foundation of this innovation is a patented technology that uses intersecting laser beams to precisely position cells within a hydrogel. The result is three-dimensional models that realistically replicate the structure and function of human tissue. “Our mission is to provide research models that are closer to humans than traditional animal models,” says co-founder Dr. Francesco Pampaloni. “This enhances the reliability of test results and can shorten development timelines.” The tissue models are particularly groundbreaking in oncology research, where they allow drug testing on human tissue before clinical trials even begin. 

Three people with prices.

The "New Horizon President's Prize" was awarded in 2025 to the founders of the startup Modulux3D: Levin Hafa, Dr. Francesco Pampaloni, and Louise Breideband (from left to right).

Award-Winning: From Research to Entrepreneurial Ap

The scientific roots of Modulux3D trace back to Goethe University Frankfurt, with the work of Professor Ernst Stelzer in the field of physical biology forming the basis for the current technology. In recognition of successfully transforming this research into an entrepreneurial application, Modulux3D was honored in 2025 with the New Horizon Award from the president of Goethe University. The jury praised the translation of basic research into a scalable product and the establishment of international partnerships. “The university provided us not only with infrastructure but also with trust,” says co-founder Louise Breideband. “This support was crucial in turning a scientific idea into a business.” Co-founder Levin Hafa adds, “Access to young talent from the RMU universities is also key for us—not just from the natural sciences but also from interdisciplinary fields like economics and engineering.”  

 

Well-Connected: Interdisciplinary and Regional (an

The founding team brings together expertise in biotechnology, cell biology, optics, and chemistry. This unique combination enables them to simultaneously address technological development, scientific validation, and market demands. Embedded in the robust Rhine-Main startup ecosystem, Modulux3D receives extensive support from the startup centers Goethe-Unibator, HIGHEST at TU Darmstadt, and Futury – The Future Factory. Today, Modulux3D is one of the region’s most promising life science startups. The current focus is on advancing LUMINATE to market readiness and expanding collaborations with pharmaceutical companies to make research more precise, efficient, and responsible.

 

Author: Heike Jüngst

 

Note: This text was translated using AI